"Manuscript describes How Cytodyn's leronlimab dis
Post# of 148292
(Total Views: 408)
Posted On: 04/22/2021 1:05:12 PM
"Manuscript describes How Cytodyn's leronlimab disrupts CCL5/RANTES-CCR5 pathway, thereby restoring Immune Homeostasis, Thereby Reducing Plasma Viral Load, Reversing Hyper-Immune Activation and Inflammation in Critical Covid-19 Patients. ***MAY 6, 2020 1:24 a.m.***
Dr.Bruce Patterson a Pathology and Virology Specialist has stated, "The Drug should be Stockpiled for FUTURE Pandemics"......That is a very Declarative statement.... that CANNOT be misunderstood in ANY way.
WE have been D!(KING around with THIS for OVER ONE YEAR.
Dr.Bruce Patterson a Pathology and Virology Specialist has stated, "The Drug should be Stockpiled for FUTURE Pandemics"......That is a very Declarative statement.... that CANNOT be misunderstood in ANY way.
WE have been D!(KING around with THIS for OVER ONE YEAR.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼